Pulmonary Research Studies (COPD and Idiopathic Pulmonary Fibrosis)

ASCENT - Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Aclidinium Bromide on Long-Term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD LAS-MD-45


BIPI 1199.177 - Multi-center open-label expanded access program of oral nintedanib 150 mg twice daily in patients with idiopathic pulmonary fibrosis.


PIPF-031 - A Treatment Protocol to Allow Patients in the US with Idiopathic Pulmonary

Fibrosis Access to Pirfenidone


To obtain information about a clinical trial being conducted at Medical Consultants, please contact us at the following:




                        Or call 765-281-2000


  To learn more information on a specific research trial, go to www.clinicaltrials.gov
For Referring Physicians
Find a Doctor
Online Billing
View Medical Records
Surgery Center Portal

Call for Info


Privacy Policy  |   Legal Notice  |   HIPAA Notice